222.21
3.26 (1.49%)
| Penutupan Terdahulu | 218.95 |
| Buka | 222.00 |
| Jumlah Dagangan | 2,385,344 |
| Purata Dagangan (3B) | 1,490,001 |
| Modal Pasaran | 36,527,292,416 |
| Harga / Pendapatan (P/E TTM) | 43.32 |
| Harga / Pendapatan (P/E Ke hadapan) | 25.71 |
| Harga / Jualan (P/S) | 12.09 |
| Harga / Buku (P/B) | 5.19 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Mar 2026 |
| Margin Keuntungan | 27.34% |
| Margin Operasi (TTM) | 30.79% |
| EPS Cair (TTM) | 4.70 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 16.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 41.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.24% |
| Nisbah Semasa (MRQ) | 4.61 |
| Aliran Tunai Operasi (OCF TTM) | 1.20 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.05 B |
| Pulangan Atas Aset (ROA TTM) | 6.90% |
| Pulangan Atas Ekuiti (ROE TTM) | 14.06% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Menurun |
| Health Information Services (Global) | Menurun | Menurun | |
| Stok | Veeva Systems Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 1.25 |
|
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 8.55% |
| % Dimiliki oleh Institusi | 86.32% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 355.00 (Needham, 59.76%) | Beli |
| Median | 319.00 (43.56%) | |
| Rendah | 280.00 (UBS, 26.01%) | Pegang |
| 280.00 (Canaccord Genuity, 26.01%) | Pegang | |
| Purata | 314.56 (41.56%) | |
| Jumlah | 6 Beli, 3 Pegang | |
| Harga Purata @ Panggilan | 247.97 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wells Fargo | 25 Nov 2025 | 333.00 (49.86%) | Beli | 239.95 |
| Citigroup | 24 Nov 2025 | 319.00 (43.56%) | Beli | 235.74 |
| BTIG | 21 Nov 2025 | 340.00 (53.01%) | Beli | 244.06 |
| Baird | 21 Nov 2025 | 319.00 (43.56%) | Beli | 244.06 |
| Barclays | 21 Nov 2025 | 305.00 (37.26%) | Beli | 244.06 |
| Canaccord Genuity | 21 Nov 2025 | 280.00 (26.01%) | Pegang | 244.06 |
| Needham | 21 Nov 2025 | 355.00 (59.76%) | Beli | 244.06 |
| UBS | 21 Nov 2025 | 280.00 (26.01%) | Pegang | 244.06 |
| BMO Capital | 13 Nov 2025 | 300.00 (35.01%) | Pegang | 291.70 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 08 Jan 2026 | Pengumuman | Veeva to Present at the J.P. Morgan 2026 Healthcare Conference |
| 08 Jan 2026 | Pengumuman | Veeva and BioMarin Form Long-Term Strategic Partnership |
| 08 Jan 2026 | Pengumuman | Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing |
| 07 Jan 2026 | Pengumuman | Novo Nordisk International Operations Commits to Veeva Vault CRM |
| 05 Jan 2026 | Pengumuman | Veeva Announces Share Repurchase Program |
| 04 Dec 2025 | Pengumuman | Veeva to Present at Upcoming Investor Conference |
| 03 Dec 2025 | Pengumuman | Veeva AI Agents Now Available to Increase Productivity and Customer Centricity |
| 24 Nov 2025 | Pengumuman | Veeva Announces Expanded Partnership with Roche |
| 20 Nov 2025 | Pengumuman | Veeva Announces Fiscal 2026 Third Quarter Results |
| 04 Nov 2025 | Pengumuman | Veeva Basics Adopted by More Than 100 Emerging Biotechs to Simplify and Standardize Operations |
| 30 Oct 2025 | Pengumuman | Veeva to Release Fiscal 2026 Third Quarter Results on November 20, 2025 |
| Papar semua | ||
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |